ROBIN SPRING: Open Payments
NPI 1114407137 · MCCOMB, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$263 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $263
Food & beverage: $263
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Lilly USA, LLC | 2 | $43 |
| Novo Nordisk Inc | 2 | $41 |
| Viatris Specialty LLC | 1 | $26 |
| Amgen Inc. | 1 | $17 |
Products named: VRAYLAR, BREZTRI, QULIPTA, JARDIANCE, YUPELRI, Rybelsus, OTEZLA, BEVESPI AEROSPHERE.
Industry payments across MS — which companies pay providers there.
